🇺🇸 FDA
Pipeline program

OPDIVO 10 mg/mL concentrate for solution for infusion., Anti-Fucosyl GM1 PET Tracer, ETOPOSIDE, CARBOPLATIN

CA001-050

Phase 2 small_molecule active

Quick answer

OPDIVO 10 mg/mL concentrate for solution for infusion., Anti-Fucosyl GM1 PET Tracer, ETOPOSIDE, CARBOPLATIN for Extensive-stage Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).

Program details

Company
Bristol-Myers Squibb / Pfizer EEIG
Indication
Extensive-stage Small Cell Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials